InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Ryali Sriram, 首席财务官. Insider active across 3 companies, notably Eiger BioPharmaceuticals, Inc.. Aggregated, 7 disclosures have been logged. Breakdown: 2 buys · 1 sell. Total volume traded: €54k. History available since 11 March 2022. The latest transaction was disclosed on 20 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ryali Sriram is Chief Financial Officer. There are 7 filings in total, and within the recent filings sample held, the transactions run from 2022-03-11 to 2026-02-20, with EUR 42,198 of buys and EUR 11,602 of sells, mainly attribution transactions.